Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ICAD | Common Stock | Options Exercise | $94.5K | +30K | +24.7% | $3.15 | 151K | Nov 8, 2021 | Direct | |
transaction | ICAD | Common Stock | Sale | -$95K | -8.75K | -5.78% | $10.86 | 143K | Nov 8, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ICAD | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -30K | -100% | $0.00* | 0 | Nov 8, 2021 | Common Stock | 30K | $3.15 | Direct |
Id | Content |
---|---|
F1 | Represents shares sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
F2 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.62 to $10.99 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it at each separate price on November 8, 2021. |